标题
Translational models of prostate cancer bone metastasis
作者
关键词
-
出版物
Nature Reviews Urology
Volume 15, Issue 7, Pages 403-421
出版商
Springer Nature
发表日期
2018-05-16
DOI
10.1038/s41585-018-0020-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- AKT in cancer: new molecular insights and advances in drug development
- (2016) Prabhjot S. Mundi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
- (2016) Christine Pasero et al. CANCER RESEARCH
- Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer
- (2016) Maija P. Valta et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases
- (2016) Toru Hiraga EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery and bio-optimization of human antibody therapeutics using the XenoMouse®transgenic mouse platform
- (2016) Ian N. Foltz et al. IMMUNOLOGICAL REVIEWS
- Real-Time GFP Intravital Imaging of the Differences in Cellular and Angiogenic Behavior of Subcutaneous and Orthotopic Nude-Mouse Models of Human PC-3 Prostate Cancer
- (2016) Yong Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
- (2015) Giovanni Luca Gravina et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression
- (2015) Yanqing Huang et al. International Journal of Biological Sciences
- The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer
- (2015) Ning Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bone metastasis and the metastatic niche
- (2015) Guangwen Ren et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Glial Cell Line-Derived Neurotrophic Factor Induces Cell Proliferation in the Mouse Urogenital Sinus
- (2015) Hyun-Jung Park et al. MOLECULAR ENDOCRINOLOGY
- Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
- (2015) Matthew T Chang et al. NATURE BIOTECHNOLOGY
- CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
- (2015) Giovanni Luca Gravina et al. PROSTATE
- Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
- (2015) Michelle A. Lawson et al. Nature Communications
- Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model
- (2015) Michael D Roth et al. Journal for ImmunoTherapy of Cancer
- An In Vivo Mouse Model for Human Prostate Cancer Metastasis
- (2015) Aaron M. Havens et al. NEOPLASIA
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment
- (2015) Younghun Jung et al. NEOPLASIA
- Next generation patient-derived prostate cancer xenograft models
- (2014) Yuzhuo Wang et al. ASIAN JOURNAL OF ANDROLOGY
- A reconstructed metastasis model to recapitulate the metastatic spread in vitro
- (2014) Mukti R. Parikh et al. Biotechnology Journal
- Molecular characterization of exosome-like vesicles from breast cancer cells
- (2014) Stefan Kruger et al. BMC CANCER
- An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer
- (2014) Song Xu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone
- (2014) Parisa Hesami et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bone-induced c-kit expression in prostate cancer: A driver of intraosseous tumor growth
- (2014) Leandro E. Mainetti et al. INTERNATIONAL JOURNAL OF CANCER
- PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche
- (2014) Elana Godebu et al. Journal of Translational Medicine
- Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment
- (2014) Yu-Chen Lee et al. MOLECULAR & CELLULAR PROTEOMICS
- Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow
- (2014) Younghun Jung et al. MOLECULAR CANCER RESEARCH
- Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening
- (2014) Eliza L. S. Fong et al. MOLECULAR PHARMACEUTICS
- RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation
- (2014) Woosook Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypernociceptive responses following the intratibial inoculation of RM1 prostate cancer cells in mice
- (2014) María Llorián-Salvador et al. PROSTATE
- Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
- (2014) M. Ono et al. Science Signaling
- Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice — A quantitative study using microCT and Raman spectroscopy
- (2013) Xiaohong Bi et al. BONE
- Human fucosyltransferase 6 enables prostate cancer metastasis to bone
- (2013) J Li et al. BRITISH JOURNAL OF CANCER
- A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
- (2013) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145
- (2013) Wei Guo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
- (2013) John C Araujo et al. LANCET ONCOLOGY
- SPARCL1 suppresses metastasis in prostate cancer
- (2013) Yuzhu Xiang et al. Molecular Oncology
- CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance
- (2013) Adam Greenbaum et al. NATURE
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Multiple metastases in a novel LNCaP model of human prostate cancer
- (2013) MINHONG ZOU et al. ONCOLOGY REPORTS
- GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
- (2013) Russell S. Taichman et al. PLoS One
- Correction: Changes in Soil Carbon and Nitrogen following Land Abandonment of Farmland on the Loess Plateau, China
- (2013) Lei Deng et al. PLoS One
- Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
- (2012) Zhihu Ding et al. CELL
- SnapShot: Bone Metastasis
- (2012) Brian Ell et al. CELL
- Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis
- (2012) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
- (2012) Omer Raheem et al. Journal of Translational Medicine
- Non-invasive MicroCT Imaging Characterization and In Vivo Targeting of BB2 Receptor Expression of a PC-3 Bone Metastasis Model
- (2012) Christopher T. Winkelmann et al. MOLECULAR IMAGING AND BIOLOGY
- Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance
- (2012) Ingrid G Winkler et al. NATURE MEDICINE
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
- (2012) P. J. Hurley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of Snail in prostate cancer
- (2012) Bethany N. Smith et al. Cell Adhesion & Migration
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model
- (2011) Lisa Wise-Milestone et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer
- (2011) J L Regan et al. ONCOGENE
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Biochemical and molecular mechanisms of action of bisphosphonates
- (2010) Michael J. Rogers et al. BONE
- Modeling prostate cancer: a perspective on transgenic mouse models
- (2010) Varinder Jeet et al. CANCER AND METASTASIS REVIEWS
- Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis
- (2010) Xin Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis
- (2010) S. A. Rabbani et al. MOLECULAR CANCER THERAPEUTICS
- Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model
- (2010) J. C. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Basal epithelial stem cells are efficient targets for prostate cancer initiation
- (2010) D. A. Lawson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases
- (2010) Nanda K. Thudi et al. PROSTATE
- Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
- (2009) T Koreckij et al. BRITISH JOURNAL OF CANCER
- Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model
- (2009) Peter Jantscheff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
- (2009) David P Dearnaley et al. LANCET ONCOLOGY
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel model of bone-metastatic prostate cancer in immunocompetent Mice
- (2009) Carl A. Power et al. PROSTATE
- Molecular mechanisms of metastasis in prostate cancer
- (2008) Noel W. Clarke et al. ASIAN JOURNAL OF ANDROLOGY
- Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
- (2008) Johanna M Tuomela et al. BMC CANCER
- Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone
- (2008) Mandeep S. Virk et al. BONE
- Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
- (2008) A C Dudley et al. BRITISH JOURNAL OF CANCER
- Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
- (2008) S.-Y. Sung et al. CANCER RESEARCH
- Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9
- (2008) Loredana Moro et al. CANCER SCIENCE
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition
- (2008) N. Patrick McCabe et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
- (2008) Haiyen E. Zhau et al. CLINICAL & EXPERIMENTAL METASTASIS
- Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
- (2008) Wenyan Lu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FGF-8 is involved in bone metastasis of prostate cancer
- (2008) Maija P. Valta et al. INTERNATIONAL JOURNAL OF CANCER
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases
- (2008) Martine P. Roudier et al. JOURNAL OF UROLOGY
- Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone
- (2008) K. Chu et al. MOLECULAR CANCER RESEARCH
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis
- (2008) Christopher L. Hall et al. PROSTATE
- RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
- (2008) K. M. Woods Ignatoski et al. PROSTATE
- Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions
- (2008) Nanda K. Thudi et al. PROSTATE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started